by Plus Therapeutics | Aug 2, 2024 | Uncategorized
Plus Therapeutics is proud to be a Bronze Supporter and Exhibitor at the SNO / ASCO CNS Conference this year! Come by our booth, posters, and presentations we have going on throughout the conference. Detail including times and presentation titles:...
by Plus Therapeutics | Aug 1, 2024 | Uncategorized
You’re Invited to our symposium “Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases,” presented at the SNO/ASCO CNS conference in Denver. More information & RSVP: https://bit.ly/4bM777e “Emerging Novel...
by Plus Therapeutics | Jul 25, 2024 | Uncategorized
UPCOMING PRESENTATIONS: Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference and scheduled to present new data, highlighting progress in its therapeutics and diagnostics programs for Leptomeningeal Metastases Read the full details...
by Plus Therapeutics | Jul 24, 2024 | Uncategorized
“Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered. To learn more about emerging developments, Digital Journal spoke with Marc Hedrick,...
by Plus Therapeutics | Jul 19, 2024 | GBM
“A lot of the battles that [GBM] picks are people that are truly going to fight back and give hope to the next patient…” ✊ Watch the full interview with Olympic Athlete & Brain Cancer Champion Scott Hamilton: https://bit.ly/4bKiufQ Social Media:...
Recent Comments